Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease
- 1 February 1993
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 100 (2) , 157-160
- https://doi.org/10.1111/j.1471-0528.1993.tb15213.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The role of low‐dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)BJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984)BJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinomaPublished by Elsevier ,1980
- Gestational Trophoblastic Disease: Origin of Choriocarcinoma, Invasive Mole and Choriocarcinoma Associated With Hydatidiform Mole, and Some Immunologic AspectsPublished by Elsevier ,1978
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- Treatment of metastatic trophoblastic disease: Good and poor prognosisAmerican Journal of Obstetrics and Gynecology, 1973